Resverlogix Corp - ESG Rating & Company Profile powered by AI
This page contains a questions and answers table on Resverlogix Corp. This webpage of Resverlogix Corp was prepared by All Street Sevva using proprietary Cognitive Robots. Scroll down to the bottom of the webpage for potential risks for Resverlogix Corp based on industry, location and marketcap.
Resverlogix Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 5.3, social score of 1.6 and governance score of 4.0.
3.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
| 1132 | Traphaco JSC | 3.7 | Medium |
| 1144 | Resverlogix Corp | 3.6 | Medium |
| 1144 | CellSeed Inc | 3.6 | Medium |
| 1144 | Cellectar Biosciences Inc | 3.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Resverlogix Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Resverlogix Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Resverlogix Corp report the average age of the workforce?
Sign up for free to unlockDoes Resverlogix Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Resverlogix Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Resverlogix Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Resverlogix Corp offer flexible work?
Sign up for free to unlockDoes Resverlogix Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Resverlogix Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Resverlogix Corp conduct supply chain audits?
Sign up for free to unlockDoes Resverlogix Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Resverlogix Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Resverlogix Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Resverlogix Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Resverlogix Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Resverlogix Corp disclose water use targets?
Sign up for free to unlockDoes Resverlogix Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Resverlogix Corp have a product recall in the last two years?
Sign up for free to unlockDoes Resverlogix Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Resverlogix Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Resverlogix Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Resverlogix Corp disclose parental leave metrics?
Sign up for free to unlockDoes Resverlogix Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Resverlogix Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Resverlogix Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Resverlogix Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Resverlogix Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Resverlogix Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Resverlogix Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Resverlogix Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Resverlogix Corp disclose its waste policy?
Sign up for free to unlockDoes Resverlogix Corp report according to TCFD requirements?
Sign up for free to unlockDoes Resverlogix Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Resverlogix Corp disclose energy use targets?
Sign up for free to unlockDoes Resverlogix Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Resverlogix Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Resverlogix Corp
These potential risks are based on the size, segment and geographies of the company.
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.